JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB272420

Anti-SARS spike glycoprotein antibody [3A2] - Coronavirus

3

(2 Reviews)

|

(23 Publications)

Mouse Monoclonal SPIKE antibody. Suitable for ICC, WB and reacts with SARS-CoV samples. Cited in 23 publications. Immunogen corresponding to Virus preparation containing SARS spike glycoprotein protein.

View Alternative Names

2, S, Spike glycoprotein, S glycoprotein, E2, Peplomer protein

4 Images
Immunocytochemistry - Anti-SARS spike glycoprotein antibody [3A2] - Coronavirus (AB272420)
  • ICC

Supplier Data

Immunocytochemistry - Anti-SARS spike glycoprotein antibody [3A2] - Coronavirus (AB272420)

Immunofluorescence analysis of SARS spike glycoprotein in Vero cells infected with the SARS-CoV2 virus.

Left image : ab272420 (1 μg/mL)

Right image : Anti-SARS-CoV2 N protein monoclonal antibody

An Alexa 488-conjugated goat anti-mouse IgG (H+L) (1/2000) was used as the secondary antibody.

ab272420 does not cross-react with SARS-CoV2.

Immunocytochemistry - Anti-SARS spike glycoprotein antibody [3A2] - Coronavirus (AB272420)
  • ICC

Supplier Data

Immunocytochemistry - Anti-SARS spike glycoprotein antibody [3A2] - Coronavirus (AB272420)

Immunofluorescence analysis of SARS spike glycoprotein in Vero cells infected with the MERS-CoV virus.

Left image : ab272420 (1 μg/mL)

Right image : Anti-MERS-CoV N protein monoclonal antibody

An Alexa 488-conjugated goat anti-mouse IgG (H+L) (1/2000) was used as the secondary antibody.

ab272420 does not cross-react with MERS-CoV.

Immunocytochemistry - Anti-SARS spike glycoprotein antibody [3A2] - Coronavirus (AB272420)
  • ICC

Supplier Data

Immunocytochemistry - Anti-SARS spike glycoprotein antibody [3A2] - Coronavirus (AB272420)

Immunofluorescence analysis of SARS spike glycoprotein in the SARS virus infected cells with ab272420 antibody at 1/1000 dilution. (a) Uninfected Vero E6 cells. (b) SARS virus infected Vero E6 cells.

Western blot - Anti-SARS spike glycoprotein antibody [3A2] - Coronavirus (AB272420)
  • WB

Supplier Data

Western blot - Anti-SARS spike glycoprotein antibody [3A2] - Coronavirus (AB272420)

All lanes:

Western blot - Anti-SARS spike glycoprotein antibody [3A2] - Coronavirus (ab272420) at 1/10000 dilution

All lanes:

Crude extract of the SARS virus infected cells

Predicted band size: 139 kDa

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

3A2

Isotype

IgG2b

Light chain type

kappa

Carrier free

No

Reacts with

SARS-CoV

Applications

WB, ICC

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

We have received mixed feedback regarding the specificity of this antibody against SARS-Cov2, please see the customer reviews section.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICC" : {"fullname" : "Immunocytochemistry", "shortname":"ICC"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "MERS-CoV": { "ICC-species-checked": "notRecommended", "ICC-species-dilution-info": "1 µg/mL", "ICC-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "" }, "SARS-CoV": { "ICC-species-checked": "testedAndGuaranteed", "ICC-species-dilution-info": "1 µg/mL", "ICC-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.1-0.3 µg/mL", "WB-species-notes": "<p></p>" }, "SARS-CoV-2": { "ICC-species-checked": "notRecommended", "ICC-species-dilution-info": "1 µg/mL", "ICC-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Product details

Applications overview

Tick: Tested and Guaranteed to work X: Will not work —: No data Reviews: Customers have been successful and shared their AbReview

<img src="https://www.abcam.com/ps/Products/272/ab272420/Images/ab272420-394499-applications-overview.jpg" height="125" width="498">

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 6.5 - 8.5 Constituents: PBS, 50% Glycerol (glycerin, glycerine)
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The SARS spike glycoprotein also known as the S glycoprotein is a critical component of the SARS-CoV-2 virus. It weighs approximately 180 kDa and can be found on the surface of the viral envelope. The spike glycoprotein facilitates the entry of the virus into host cells by binding to the angiotensin-converting enzyme 2 (ACE2) receptor. This protein is often targeted by monoclonal antibodies and vaccine strategies aimed at preventing infection. Researchers isolate antibodies that bind specifically to the spike contributing to the development of therapeutic agents like anti-spike monoclonal antibodies.
Biological function summary

The spike glycoprotein serves a fundamental role in the viral life cycle by mediating fusion between the viral membrane and host cell membranes. Its function is divided into two subunits: S1 which is responsible for receptor binding and S2 which is important for membrane fusion. Upon receptor binding a conformational change in the glycoprotein occurs triggering fusion events critical for viral entry. This protein is not typically part of a larger complex but operates in tandem with viral envelope proteins to facilitate replication.

Pathways

The spike glycoprotein's interaction with the host cell's ACE2 receptor places it within the renin-angiotensin-aldosterone system (RAAS) affecting several downstream signaling pathways. The binding initiates endocytosis of the virus into the host cell and impacts inflammation pathways and immune response mechanisms involving interleukin proteins. The spike protein shares functional relationships with other viral proteins such as nucleocapsid and membrane proteins contributing to the virion's structure and infection process.

The spike glycoprotein is closely associated with COVID-19 and the disease's ability to spread and mutate. It's a central focus in the development of potential treatments and vaccines given its role in viral entry. Some mutations in the spike protein can enhance transmissibility or resistance to neutralization influencing the course of infection. In seeking therapeutic interventions researchers focus on spike-related interactions with host proteins like ACE2 which are important in managing COVID-19 symptoms and complications.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Spike protein S1. Attaches the virion to the cell membrane by interacting with host receptor, initiating the infection. The major receptor is host ACE2 (PubMed : 32142651, PubMed : 32155444, PubMed : 33607086). When S2/S2' has been cleaved, binding to the receptor triggers direct fusion at the cell membrane (PubMed : 34561887). When S2/S2' has not been cleaved, binding to the receptor results in internalization of the virus by endocytosis leading to fusion of the virion membrane with the host endosomal membrane (PubMed : 32075877, PubMed : 32221306). Alternatively, may use NRP1/NRP2 (PubMed : 33082294, PubMed : 33082293) and integrin as entry receptors (PubMed : 35150743). The use of NRP1/NRP2 receptors may explain the tropism of the virus in human olfactory epithelial cells, which express these molecules at high levels but ACE2 at low levels (PubMed : 33082293). The stalk domain of S contains three hinges, giving the head unexpected orientational freedom (PubMed : 32817270).. Spike protein S2. Precursor of the fusion protein processed in the biosynthesis of the S protein and the formation of virus particle. Mediates fusion of the virion and cellular membranes by functioning as a class I viral fusion protein. Contains two viral fusion peptides that are unmasked after cleavage. The S2/S2' cleavage occurs during virus entry at the cell membrane by host TMPRSS2 (PubMed : 32142651) or during endocytosis by host CSTL (PubMed : 32703818, PubMed : 34159616). In either case, this triggers an extensive and irreversible conformational change leading to fusion of the viral envelope with the cellular cytoplasmic membrane, releasing viral genomic RNA into the host cell cytoplasm (PubMed : 34561887). Under the current model, the protein has at least three conformational states : pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During fusion of the viral and target cell membranes, the coiled coil regions (heptad repeats) adopt a trimer-of-hairpins structure and position the fusion peptide in close proximity to the C-terminal region of the ectodomain. Formation of this structure appears to promote apposition and subsequent fusion of viral and target cell membranes.. Spike protein S2'. Subunit of the fusion protein that is processed upon entry into the host cell. Mediates fusion of the virion and cellular membranes by functioning as a class I viral fusion protein. Contains a viral fusion peptide that is unmasked after S2 cleavage. This cleavage can occur at the cell membrane by host TMPRSS2 or during endocytosis by host CSTL (PubMed : 32703818, PubMed : 34159616). In either case, this triggers an extensive and irreversible conformational change that leads to fusion of the viral envelope with the cellular cytoplasmic membrane, releasing viral genomic RNA into the host cell cytoplasm (PubMed : 34561887). Under the current model, the protein has at least three conformational states : pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During fusion of the viral and target cell membranes, the coiled coil regions (heptad repeats) adopt a trimer-of-hairpins structure and position the fusion peptide in close proximity to the C-terminal region of the ectodomain. Formation of this structure appears to promote apposition and subsequent fusion of viral and target cell membranes.
See full target information S

Publications (23)

Recent publications for all applications. Explore the full list and refine your search

Molecular psychiatry : PubMed41053436

2025

Regulation of stress susceptibility by chromatin-binding protein PHF6 in the pituitary intermediate lobe.

Applications

Unspecified application

Species

Unspecified reactive species

Bing Liu,Jingjie Wang,Xiaohua Wu,Linhua Gan,Jingjing Sun,Guangzhong Wang,Qian Li,Ju Huang

Acta neuropathologica 148:11 PubMed39060438

2024

High throughput spatial immune mapping reveals an innate immune scar in post-COVID-19 brains.

Applications

Unspecified application

Species

Unspecified reactive species

Marius Schwabenland,Dilara Hasavci,Sibylle Frase,Katharina Wolf,Nikolaus Deigendesch,Joerg M Buescher,Kirsten D Mertz,Benjamin Ondruschka,Hermann Altmeppen,Jakob Matschke,Markus Glatzel,Stephan Frank,Robert Thimme,Juergen Beck,Jonas A Hosp,Thomas Blank,Bertram Bengsch,Marco Prinz

Frontiers in neurology 14:1229641 PubMed37521293

2023

Neuropathology in COVID-19 autopsies is defined by microglial activation and lesions of the white matter with emphasis in cerebellar and brain stem areas.

Applications

Unspecified application

Species

Unspecified reactive species

Julian A Stein,Manuel Kaes,Sigrun Smola,Walter J Schulz-Schaeffer

Free neuropathology 4: PubMed37283933

2023

Golgi localization of SARS-CoV-2 spike protein and interaction with furin in cerebral COVID-19 microangiopathy: a clue to the central nervous system involvement?

Applications

Unspecified application

Species

Unspecified reactive species

Susana Boluda,Karima Mokhtari,Bruno Mégarbane,Djillali Annane,Bertrand Mathon,Albert Cao,Clovis Adam,Alexandre Androuin,Franck Bielle,Guy Brochier,Frédéric Charlotte,Lydia Chougar,Khalid Hamid El Hachimi,Marc Eloit,Stéphane Haïk,Dominique Hervé,Amal Kasri,Valentin Leducq,Stéphane Lehéricy,Etienne Levavasseur,Christian Lobsiger,Geoffroy Lorin de La Grandmaison,Isabelle Malet,Isabelle Malissin,Stéphane Marot,Serge Marty,Philippe Pérot,Isabelle Plu,Annick Prigent,Lev Stimmer,Marie-Claude Potier,Anne-Geneviève Marcelin,Benoît Delatour,Charles Duyckaerts,Danielle Seilhean

International journal of molecular sciences 23: PubMed35216056

2022

Loss of Detection of sgN Precedes Viral Abridged Replication in COVID-19-Affected Patients-A Target for SARS-CoV-2 Propagation.

Applications

Unspecified application

Species

Unspecified reactive species

Veronica Ferrucci,Pasqualino de Antonellis,Fabrizio Quarantelli,Fatemeh Asadzadeh,Francesca Bibbò,Roberto Siciliano,Carmen Sorice,Ida Pisano,Barbara Izzo,Carmela Di Domenico,Angelo Boccia,Maria Vargas,Biancamaria Pierri,Maurizio Viscardi,Sergio Brandi,Giovanna Fusco,Pellegrino Cerino,Livia De Pietro,Ciro Furfaro,Leonardo Antonio Napolitano,Giovanni Paolella,Lidia Festa,Stefania Marzinotto,Maria Concetta Conte,Ivan Gentile,Giuseppe Servillo,Francesco Curcio,Tiziana de Cristofaro,Francesco Broccolo,Ettore Capoluongo,Massimo Zollo

Biotechnology reports (Amsterdam, Netherlands) 32:e00681 PubMed34611521

2021

ACE2-cytomimetic particles restrict SARS-Cov-2 spike protein binding to cellular targets.

Applications

Unspecified application

Species

Unspecified reactive species

Thomas A Strong,Daniel Pelaez

Cells 10: PubMed34440669

2021

Multisystemic Cellular Tropism of SARS-CoV-2 in Autopsies of COVID-19 Patients.

Applications

Unspecified application

Species

Unspecified reactive species

Dickson W L Wong,Barbara M Klinkhammer,Sonja Djudjaj,Sophia Villwock,M Cherelle Timm,Eva M Buhl,Sophie Wucherpfennig,Claudio Cacchi,Till Braunschweig,Ruth Knüchel-Clarke,Danny Jonigk,Christopher Werlein,Roman D Bülow,Edgar Dahl,Saskia von Stillfried,Peter Boor

Neuropathology and applied neurobiology 48:e12752 PubMed34297438

2021

Olfactory bulb SARS-CoV-2 infection is not paralleled by the presence of virus in other central nervous system areas.

Applications

Unspecified application

Species

Unspecified reactive species

Gianluca Lopez,Cristina Tonello,Ganna Osipova,Luca Carsana,Mara Biasin,Gioia Cappelletti,Alessandro Pellegrinelli,Eleonora Lauri,Pietro Zerbi,Roberta Simona Rossi,Manuela Nebuloni

Science signaling 14: PubMed34230209

2021

Long-chain polyphosphates impair SARS-CoV-2 infection and replication.

Applications

Unspecified application

Species

Unspecified reactive species

Veronica Ferrucci,Dae-Young Kong,Fatemeh Asadzadeh,Laura Marrone,Angelo Boccia,Roberto Siciliano,Giuseppina Criscuolo,Camilla Anastasio,Fabrizio Quarantelli,Marika Comegna,Ida Pisano,Margherita Passariello,Ilaria Iacobucci,Rosa Della Monica,Barbara Izzo,Pellegrino Cerino,Giovanna Fusco,Maurizio Viscardi,Sergio Brandi,Bianca Maria Pierri,Giorgia Borriello,Claudia Tiberio,Luigi Atripaldi,Martina Bianchi,Giovanni Paolella,Ettore Capoluongo,Giuseppe Castaldo,Lorenzo Chiariotti,Maria Monti,Claudia De Lorenzo,Kyong-Seop Yun,Stefano Pascarella,Jae-Ho Cheong,Hong-Yeoul Kim,Massimo Zollo

Nature 595:565-571 PubMed34153974

2021

Dysregulation of brain and choroid plexus cell types in severe COVID-19.

Applications

Unspecified application

Species

Unspecified reactive species

Andrew C Yang,Fabian Kern,Patricia M Losada,Maayan R Agam,Christina A Maat,Georges P Schmartz,Tobias Fehlmann,Julian A Stein,Nicholas Schaum,Davis P Lee,Kruti Calcuttawala,Ryan T Vest,Daniela Berdnik,Nannan Lu,Oliver Hahn,David Gate,M Windy McNerney,Divya Channappa,Inma Cobos,Nicole Ludwig,Walter J Schulz-Schaeffer,Andreas Keller,Tony Wyss-Coray
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com